Marble, columns and stairs
Feb 18, 2015

On February 10, 2015, Detour Gold Corporation (“Detour Gold“) completed a bought deal prospectus offering of 12,650,000 common shares at a price of $12.80 per share for aggregate gross proceeds of $161,920,000. The offering included 1,650,000 common shares issued pursuant to the full exercise of the underwriters’ over-allotment option.

The syndicate of underwriters was led by BMO Capital Markets, and included CIBC World Markets Inc., RBC Dominion Securities Inc., TD Securities Inc., Scotia Capital Inc., National Bank Financial Inc., Canaccord Genuity Corp., Cormark Securities Inc., Credit Suisse Securities (Canada), Inc., Desjardins Securities Inc., Dundee Securities Ltd., Goldman Sachs Canada Inc., Haywood Securities Inc., Macquarie Capital Markets Canada Ltd., Merrill Lynch Canada Inc., Raymond James Ltd., Beacon Securities Limited, GMP Securities L.P., Laurentian Bank Securities Inc., Morgan Stanley Canada Limited and Paradigm Capital Inc.

Detour Gold was represented by Julie Galloway, Senior Vice President, General Counsel and Corporate Secretary of Detour Gold, and by McMillan LLP with a team that included Jason Chertin and Sandra Zhao (capital markets), Herb Ono (U.S. securities), Matt German (real estate) and Carl Irvine (tax).

The syndicate of underwriters was represented by Norton Rose Fulbright Canada LLP with a team that included Robert Mason, Sarah Osman (corporate finance and securities) and Barry Segal (tax).